ask="N/A"
ask_size="N/A"
average_daily_volume="393016"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="-1.32"
change_from_200_day_moving_average="-0.93"
change_from_50_day_moving_average="-5.31"
change_from_52_week_high="-12.36"
change_From_52_week_low="20.61"
change_in_percent="-2.64%"
close="48.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="50.80"
high_52_weeks="60.98"
last_trade_date="1/13/2017"
last_trade_price="48.62"
last_trade_size="30875"
last_trade_time="4:00pm"
low="48.41"
low_52_weeks="28.01"
market_capitalization="1.32B"
moving_average_200_day="49.55"
moving_average_50_day="53.93"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="50.20"
pe_ratio="5.43"
peg_ratio="0.38"
percent_change_from_200_day_moving_average="-1.88%"
percent_change_from_50_day_moving_average="-9.85%"
percent_change_from_52_week_high="-20.27%"
percent_change_from_52_week_low="+73.58%"
previous_close="49.94"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.36"
price_per_sales="3.51"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.50"
stock_exchange="NMS"
symbol="FPRX"
volume="311089"
weeks_range_52="28.01 - 60.98"
